{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:24:10Z","timestamp":1792020250753,"version":"4.4.0"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/jac\/dkx451","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T20:21:12Z","timestamp":1511814072000},"page":"i73-i81","source":"Crossref","is-referenced-by-count":29,"title":["Biofilms and beyond: expanding echinocandin utility"],"prefix":"10.1093","volume":"73","author":[{"given":"Emily L","family":"Larkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharvari","family":"Dharmaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A","family":"Ghannoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"key\n\t\t\t\t20180103070549_dkx451-B1","first-page":"574","article-title":"Amphotericins A and B: two new antifungal antibiotics possessing high activity against deep-seated and superficial mycoses","volume":"3","year":"1955","journal-title":"Antibiot Annu"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B2","first-page":"15","article-title":"Discovery and development of first in class antifungal caspofungin (CANCIDAS(R))\u2013a case study","volume":"31","year":"2013","journal-title":"Nat Prod Rep"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B3","author":"Federal Label for Mycamine(micafungin)","year":"2016"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B4","year":"2012"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1592\/phco.29.1.17","article-title":"Pharmacology and antifungal properties of anidulafungin, a new echinocandin","volume":"29","year":"2009","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0014-5793(84)81032-7","article-title":"Echinocandin inhibition of 1,3-\u03b2-d-glucan synthase from Candida albicans","volume":"173","year":"1984","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B7","first-page":"651","article-title":"Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs","volume":"34","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.coph.2013.08.008","article-title":"Antifungal therapy with an emphasis on biofilms","volume":"13","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/jac\/dkm330","article-title":"Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms","volume":"60","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","year":"2003","journal-title":"Trends Microbiol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.46.1.245-247.2002","article-title":"In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp","volume":"46","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B12","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s40265-014-0286-5","article-title":"Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management","volume":"74","year":"2014","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9378(98)80001-X","article-title":"Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations","volume":"178","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B16","first-page":"19","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20180103070549_dkx451-B18","first-page":"i60","article-title":"Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies","volume":"73","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/AAC.50.1.143-147.2006","article-title":"Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B20","article-title":"Antifungal prophylaxis with anidulafungin to minimize drug interactions with an antiepileptic treatment in a hematopoietic stem cell transplant recipient","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1471-2334-12-151","article-title":"Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis","volume":"12","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clinthera.2013.11.010","article-title":"Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis","volume":"36","year":"2014","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B23","doi-asserted-by":"crossref","first-page":"e0180050","DOI":"10.1371\/journal.pone.0180050","article-title":"Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: a meta-analysis of randomized controlled trials","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/clind\/24.4.649","article-title":"Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy","volume":"24","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.diagmicrobio.2014.02.016","article-title":"Candidemia surveillance in Iowa: emergence of echinocandin resistance","volume":"79","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B26","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1128\/AAC.00620-16","article-title":"Characterization of in vitro resistance development to the novel echinocandin CD101 in Candida species","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20180103070549_dkx451-B27","first-page":"i4","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1:","key":"key\n\t\t\t\t20180103070549_dkx451-B28","first-page":"i44","article-title":"We can do better: a fresh look at echinocandin dosing","volume":"73","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B29","article-title":"Activity of a long-acting echinocandin (CD101) and seven comparator antifungal agents tested against a global collection of contemporary invasive fungal isolates in the SENTRY 2014 Antifungal Surveillance Program","volume":"61","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B30","article-title":"Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults","volume":"61","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ja.2016.89","article-title":"CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility","volume":"70","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B32"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B33"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B34"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B35","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/cmi.12640","article-title":"CD101: a novel long-acting echinocandin","volume":"18","year":"2016","journal-title":"Cell Microbiol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B36","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1128\/AAC.00701-16","article-title":"Preclinical evaluation of the stability, safety, and efficacy of CD101, a novel echinocandin","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B37","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/jac\/dkw214","article-title":"Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B38"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B39"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B40"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B41","article-title":"De novo acquisition of resistance to SCY-078 in Candida glabrata involves FKS mutations that both overlap and are distinct from those conferring echinocandin resistance","volume":"16","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B42","first-page":"1769","article-title":"The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp","volume":"72","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B43","doi-asserted-by":"crossref","first-page":"e33705","DOI":"10.1371\/journal.pone.0033705","article-title":"Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B44","doi-asserted-by":"crossref","first-page":"S622","DOI":"10.1093\/cid\/civ746","article-title":"Role of echinocandins in fungal biofilm-related disease: vascular catheter-related infections, immunomodulation, and mucosal surfaces","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B45","first-page":"53","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B46","doi-asserted-by":"crossref","first-page":"26860","DOI":"10.1038\/srep26860","article-title":"Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts","volume":"6","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B47","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","article-title":"Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance","volume":"183","year":"2001","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B48","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B49","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/AAC.48.5.1727-1732.2004","article-title":"Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jac\/dkp242","article-title":"Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis","volume":"64","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jcpt.12108","article-title":"Cardiac toxicity of the echinocandins: chance or cause and effect association?","volume":"39","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jiac.2015.05.007","article-title":"In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms","volume":"21","year":"2015","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B53","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1128\/AAC.03065-15","article-title":"Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in echinocandin-resistant yeast species","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B54","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1128\/AAC.02344-12","article-title":"Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B55","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1567-1364.2010.00618.x","article-title":"Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model","volume":"10","year":"2010","journal-title":"FEMS Yeast Res"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B56","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1128\/IAI.00480-10","article-title":"Development and validation of an in vivo Candida albicans biofilm denture model","volume":"78","year":"2010","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/dkn160","article-title":"In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth","volume":"62","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B58","first-page":"15","article-title":"Recurrent vulvovaginal candidiasis","volume":"214","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B59","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1099\/mic.0.039354-0","article-title":"Candida albicans forms biofilms on the vaginal mucosa","volume":"156","year":"2010","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B60","first-page":"68","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS","volume":"18","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B61","first-page":"e1","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B62","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/jac\/dkx008","article-title":"In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis","volume":"72","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B63"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B64","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.04867-14","article-title":"Candida infective endocarditis: an observational cohort study with a focus on therapy","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B65","first-page":"152","article-title":"Incidence and outcome of documented fungal endocarditis","volume":"8","year":"2015","journal-title":"Int Cardiovasc Res J"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B66","doi-asserted-by":"crossref","first-page":"S618","DOI":"10.1093\/cid\/civ815","article-title":"The role of echinocandins in Candida biofilm-related vascular catheter infections: in vitro and in vivo model systems","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B67","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/650454","article-title":"Risk factors and outcomes of fungal ventricular-assist device infections","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B68","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1540-8191.2009.00919.x","article-title":"Fungemia associated with left ventricular assist device support","volume":"24","year":"2009","journal-title":"J Card Surg"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B69","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0003-4975(00)01444-2","article-title":"Fungal left ventricular assist device endocarditis","volume":"71","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5582\/irdr.2016.01049","article-title":"Endocarditis in left ventricular assist device","volume":"5","year":"2016","journal-title":"Intractable Rare Dis Res"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B71"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B72","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/JCM.00131-07","article-title":"Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia","volume":"45","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B73","first-page":"e01951","article-title":"Cooperative evolutionary strategy between the bacteriome and mycobiome","volume":"7","year":"2016","journal-title":"MBio"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B74","article-title":"Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn's disease","volume":"7","year":"2016","journal-title":"MBio"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B75","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.chom.2012.10.012","article-title":"Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications","volume":"12","year":"2012","journal-title":"Cell Host Microbe"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B76","article-title":"Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing","volume":"7","year":"2016","journal-title":"MBio"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B77","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1365-2036.2010.04444.x","article-title":"The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis","volume":"32","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B78","first-page":"107","article-title":"Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa","volume":"60","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","year":"2009","journal-title":"Microbiol Immunol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B80","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1128\/JCM.00319-11","article-title":"First three reported cases of nosocomial fungemia caused by Candida auris","volume":"49","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","article-title":"First hospital outbreak of the globally emerging Candida auris in a European hospital","volume":"5","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B82","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B83","first-page":"919","article-title":"Multidrug-resistant endemic clonal strain of Candida auris in India","volume":"33","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B84","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.00367-15","article-title":"Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method","volume":"53","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B85","article-title":"The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation","volume":"61","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B86","article-title":"Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values","volume":"61","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B87"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B88"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B89","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/B978-1-4160-5680-5.00016-5","volume-title":"Clinical Mycology","year":"2009"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/106002809703100412","article-title":"Oral terbinafine: a new antifungal agent","volume":"31","year":"1997","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B91","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/14656566.2012.681779","article-title":"New therapeutic options for onychomycosis","volume":"13","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/2229-5178.178099","article-title":"Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review","volume":"7","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B93","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/myc.12315","article-title":"In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs","volume":"58","year":"2015","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B94","first-page":"141","article-title":"In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China","volume":"175","year":"2012","journal-title":"Mycopathologia"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B95"},{"key":"key\n\t\t\t\t20180103070549_dkx451-B96","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/13693780903373811","article-title":"Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model","volume":"48","year":"2010","journal-title":"Med Mycol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/suppl_1\/i73\/23002701\/dkx451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T15:22:29Z","timestamp":1514992949000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/73\/suppl_1\/i73\/4769713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":96,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2018,1,3]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx451","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2018,1,1]]}}}